SCHEMBL1057547

SCHEMBL1057547

CCC(NC(CO)(CO)CO)NC(CO)(CO)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL14058174 0.97 ABCC3 (0.32)
SCHEMBL20988124 0.78 LMNA (0.40)
SCHEMBL19091152 0.76 CA12 (0.34)
SCHEMBL19215767 0.76 TSHR (0.32)
SCHEMBL525806 0.71 TSHR (0.32)
SCHEMBL2583905 0.70 LMNA (0.34)
SCHEMBL12268483 0.70 TSHR (0.33)
SCHEMBL9755293 0.69 TDP1 (0.35)
SCHEMBL19769924 0.67 TSHR (0.32)
SCHEMBL20787616 0.67 LMNA (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 286 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230310615-A1 OPHTHALMIC COMPOSITIONS ALCON INC. (CH) 2023-10-05 US claimed
WO-2023187672-A1 OPHTHALMIC COMPOSITIONS ALCON INC. (CH) 2023-10-05 WO claimed
EP-3908674-A1 OLIGONUCLEOTIDE DEPOSITION ONTO POLYPROPYLENE SUBSTRATES QuantuMDx Group Limited (GB) 2021-11-17 EP claimed
WO-2020144454-A1 OLIGONUCLEOTIDE DEPOSITION ONTO POLYPROPYLENE SUBSTRATES QUANTUMDX GROUP LIMITED (GB) 2020-07-16 WO claimed
US-20170153202-A1 DEVICE AND METHOD FOR SEPARATION AND ANALYSIS OF TRACE AND ULTRA-TRACE IONOGENIC COMPOUNDS BY ISOTACHOPHORESIS AND ZONE ELECTROPHORESIS ON CHIP DOLNIK VLADISLAV (US) 2017-06-01 US claimed
US-20120301406-A1 SKIN CARE COMPOSITION WITH INDICATING FUNCTION AND METHOD OF USING THE SAME TAIWAN TEXTILE RESEARCH INSTITUTE (TW) 2012-11-29 US claimed
EP-2449374-A1 SENSOR FILMS, METHODS FOR MAKING AND METHODS FOR MONITORING WATER-SOLUBLE POLYMER CONCENTRATIONS General Electric Company (US) 2012-05-09 EP claimed
WO-2011002642-A1 SENSOR FILMS, METHODS FOR MAKING AND METHODS FOR MONITORING WATER-SOLUBLE POLYMER CONCENTRATIONS GENERAL ELECTRIC COMPANY (US) 2011-01-06 WO claimed
EP-1345952-B1 ISOLATION OF NUCLEIC ACIDS DNA RES INNOVATIONS LTD (GB) 2004-11-24 EP claimed
EP-1448607-A1 COMPOSITION AND METHOD TO HOMOGENEOUSLY MODIFY OR CROSS-LINK CHITOSAN UNDER NEUTRAL CONDITIONS Biosyntech Canada Inc. (CA) 2004-08-25 EP claimed
WO-2003042250-A1 COMPOSITION AND METHOD TO HOMOGENEOUSLY MODIFY OR CROSS-LINK CHITOSAN UNDER NEUTRAL CONDITIONS BIOSYNTECH CANADA INC. (CA) 2003-05-22 WO claimed
EP-1171561-A1 DETERGENT COMPOSITION COMPRISING ANTI-HAZING AGENT THE PROCTER & GAMBLE COMPANY (US) 2002-01-16 EP claimed
WO-2000063333-A1 DETERGENT COMPOSITION COMPRISING ANTI-HAZING AGENT THE PROCTER & GAMBLE COMPANY (US) 2000-10-26 WO claimed
EP-0722492-A1 STABILISATION OF PROTEINS IN SOLUTION The University of Leeds Innovations Ltd. (GB) 1996-07-24 EP claimed
WO-1995010605-A1 STABILISATION OF PROTEINS IN SOLUTION THE UNIVERSITY OF LEEDS INNOVATIONS LTD. (GB) 1995-04-20 WO claimed
US-20250382659-A1 KITS AND METHODS FOR BIOLOGICAL SAMPLE PROCESSING GEN PROBE INC (US) 2025-12-18 US disclosed
EP-4653527-A2 USE OF A COMPOSITION AND METHOD FOR BIOLOGICAL SAMPLE PROCESSING Gen-Probe Incorporated (US) 2025-11-26 EP disclosed
WO-1997009428-A9 COMPOUNDS AND METHODS FOR IMMUNOTHERAPY AND DIAGNOSIS OF TUBERCULOSIS 1997-05-15 WO disclosed
WO-1997009429-A2 COMPOUNDS AND METHODS FOR DIAGNOSIS OF TUBERCULOSIS CORIXA CORPORATION (US) 1997-03-13 WO disclosed
WO-1997009428-A2 COMPOUNDS AND METHODS FOR IMMUNOTHERAPY AND DIAGNOSIS OF TUBERCULOSIS CORIXA CORPORATION (US) 1997-03-13 WO disclosed